Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

Find more HIMSS24 conference coverage here

A New Partnership for Growth

Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

Exciting New Features at HIMSS24

At HIMSS2024, with this new collaboration comes new features, including:

• A Digital Health Technology Theme Park, filled with innovations that revolve around AI, workforce and the business of healthcare;
• The Government Connections Plaza, featuring the latest rundown from Washington;
• A reimagined Interoperability Showcase for a deeper dive into the inner workings of healthcare;
• Hot topics will be featured on the exhibition Main Stage; and
• A Hosted Buyer Program, facilitating focused meetings between providers and trusted companies in healthcare technology.

Related content:

Find more HIMSS24 conference coverage here

HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

VIDEO: Using Maturity Models to Measure Digital Health

VIDEO: Moving Digital Transformation Forward in Healthcare

VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

Clinicians and referring physicians need fast, secure access to both patient data and their diagnostic or viewing tool set. But the cost barriers and the complexity of owning and maintaining healthcare information systems can compromise the quality of care.

To address this, Philips has partnered with AWS to develop Philips HealthSuite Imaging — a new radiology cloud service that provides on-demand access to advanced medical imaging software.

ITN recently visited with Madhuri Sebastian and Matthieu Ferrant to learn more about this service.

Find more RSNA23 conference coverage here

At RSNA23, Imaging Technology News (ITN) spoke with Bhvita Jani, principal analyst at Signify Research, about advancements and trends in medical imaging, including the development of coronary CTA, use of molecular imaging in theranostic applications, and remote acquisition support, as well as future outlooks and the evolution of medical imaging.

Related content:

VIDEO: Data Workflow and Orchestration in Medical Imaging

VIDEO: One on One with Curtis P. Langlotz, MD, PhD, RSNA President

Find more RSNA23 conference coverage here

View the RSNA23 Photo Gallery here

One on One ... with Curtis P. Langlotz, MD, PhD

Updates on AI in Radiology, RSNA Programs and Stanford Initiatives 

Listen and learn with ITN’s newest “One on One” video discussion with a leader in the field of artificial intelligence (AI). RSNA President Curtis P. Langlotz, MD, PhD, Stanford University, offers not-to-be-missed actionable insights into the application and benefits of artificial intelligence in medical imaging. He also shares highlights from RSNA 2023 and top priorities in the coming year, and summarizes the programs on which he and his Stanford University colleagues are focused.

Related content:

Find more RSNA23 conference coverage here

View the RSNA23 Photo Gallery here

One on One ... with Curtis P. Langlotz, MD, PhD

Tune in to ITN’s latest “One on One” video series with Michael Butkus, PhD, for insights into proton therapy advancements. Butkus is the co-medical director and head of proton physics at the Dwoskin Proton Center at the Sylvester Comprehensive Cancer Center, part of the University of Miami/UHealth Medical System. A board member of the National Association of Proton Therapy (NAPT), Butkus spoke with ITN’s managing editor to discuss how physicists, physicians and vendors are collaborating to expand availability of proton therapy and improve the health of patients being treated. 

Related proton therapy content:

Targeting Cancer, Tracking Collaboration: A Progress Report on Proton Therapy

ASTRO23 conference coverage

VIDEO: First FLASH Proton Therapy Trial Completed in Humans

Bayer Calantic and Blackford Analysis have teamed up with new artificial intelligence (AI) innovations to address the radiology challenges of today and tomorrow.

Imaging Technology News recently spoke with Thanos Karras, Head of Bayer Digital Solutions Business Americas, and Ben Panter, Founder and CEO of Blackford Analysis, to learn more about this new relationship and their strategy to drive radiology advancements with artificial intelligence.

Related Bayer Artificial Intelligence Content:

Bayer Offers The Complete Guide to Artificial Intelligence in Radiology, a Free eBook

Bayer Announces Acquisition of Blackford Analysis to Advance AI in Radiology Imaging

Talking Trends with Bayer: Transforming Radiology with Digital Solutions

Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. ITN spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

Find more HIMSS23 coverage here

VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

Related Digital Transformation Content:

VIDEO: Moving Digital Transformation Forward in Healthcare

VIDEO: Using Maturity Models to Measure Digital Health

Cybersecurity: How Healthcare is at Risk

VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

C-COMM: HIMSS New Non-Acute Care Digital Maturity Model

HIMSS Leadership Pinpoints Priority Issues for 2023 Global Conference

VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

New Non-Acute Care Roadmap: HIMSS Digital Maturity Model Strategy

Successfully creating and implementing artificial intelligence (AI) and analytic solutions in general requires a number of key factors, including data quality and a certain level of expertise. ITN had a conversation with Julius Bogdan, a leading expert in Digital transformation, Data and analytics, and Artificial intelligence and machine learning, to learn more about the key components needed to create and implement AI and digital transformation solutions.

Julius is Vice President and General Manager, Digital Health Advisory Team for the Healthcare Information and Management Systems Society (HIMSS). In that role, he leads sales, business development, product management, product marketing and advisory services teams across the continent on digital health transformation. He is responsible for the growth of the HIMSS Analytics portfolio adoption, channel strategy, and cultivating relationships across the provider, payer and public sector health landscape. He also serves on the advisory council of various start-ups and early stage firms in finance and healthcare on technology trends, architecture and market analysis.

Find more HIMSS23 content here 

VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

Related Digital Transformation Content:

VIDEO: Moving Digital Transformation Forward in Healthcare

VIDEO: Using Maturity Models to Measure Digital Health

Cybersecurity: How Healthcare is at Risk

VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

C-COMM: HIMSS New Non-Acute Care Digital Maturity Model

HIMSS Leadership Pinpoints Priority Issues for 2023 Global Conference

VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

New Non-Acute Care Roadmap: HIMSS Digital Maturity Model Strategy

This year at HIMSS, the theme is Health That Connects + Tech That Cares, and cybersecurity is indeed a part of this picture. ITN spoke with Lee Kim, who is the Senior Principal, Cybersecurity and Privacy at the Healthcare Information and Management Systems Society (HIMSS), on cybersecurity and how healthcare is at risk. In the video, Lee also discusses the 2022 HIMSS Healthcare Cybersecurity Survey, which reflects the opinions of healthcare cybersecurity professionals. You can more information about the survey results here.

Find more HIMSS23 content here 

2022 HIMSS Healthcare Cybersecurity Survey Report Results Published

VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

Related Digital Transformation Content:

VIDEO: Moving Digital Transformation Forward in Healthcare

VIDEO: Using Maturity Models to Measure Digital Health

Cybersecurity: How Healthcare is at Risk

VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

C-COMM: HIMSS New Non-Acute Care Digital Maturity Model

HIMSS Leadership Pinpoints Priority Issues for 2023 Global Conference

VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

New Non-Acute Care Roadmap: HIMSS Digital Maturity Model Strategy

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research, development, and manufacture of a new contrast agent.

Imaging Technology News talked to Jeff Fleming, president and CEO, at RSNA 2022 to learn more about this relationship and find out what Bracco is doing for the future of radiology.

For more information: www.vueway.com

Find more RSNA22 coverage here

Related content:

Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent

First Nationwide Use of Bracco's VUEWAY (gadopiclenol) Solution for Injection for MRI

Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem (Gadopiclenol) Injection

To mitigate the overwhelming volume of radiology data compounding staff shortages and burnout, Philips AI Solutions helps empower radiology departments by enabling radiologists to efficiently leverage artificial intelligence in their daily clinical routine.  

Philips AI Manager provides a tool that integrates with existing IT and PACS infrastructures, delivering seamless integration of AI benefits into radiology workflow at the point of care.  

Imaging Technology News talked with Tanuj Gupta and Kevin Lev at RSNA22 to learn more about Philips’ AI Solutions.  

Find more RSNA22 coverage here 

Konica Minolta Healthcare recently announced it is working with Amazon Web Services to offer its cloud-based Exa Platform and Symmetry PACS as a Software as a Service model in the Cloud.

Imaging Technology News spoke with Konica Minolta's Kevin Borden and Ash Dhar of AWS at RSNA to learn more about this new venture and how Konica Minolta and Amazon Web Services are working together.

Related Content:

Konica Minolta Healthcare to Extend Exa Platform to the Cloud with AWS

BLOG: Improving Productivity and Simplifying Patient Eligibility for Imaging Practices

Legent Imaging Increases Revenue, Decreases Rejected Claims with Exa Platform and Revenue Cycle Management Solution

Find more RSNA22 coverage here 

Kim Sandler, MD, Co-Chair of the American College of Radiology (ACR) Lung Cancer Screening Steering Committee, and Associate Professor, Department of Radiology at Vanderbilt University Medical Center, recently shared updates on research and initiatives for expanding life-saving lung cancer screenings. This video is part of ITN's Special Report on Lung Cancer Screening, a 3-part series focused on news and resources addressing the leading cause of U.S. cancer deaths.

Related Lung Imaging Content:  

Special Report on Lung Cancer and Screening Initiatives

Special Report on Lung Cancer and Screening Initiatives, Part II

American Lung Association Addresses Awareness on World Lung Cancer Day 

MRI Sheds Light on COVID Vaccine-Associated Heart Muscle Injury  

What We Know About Cardiac Long-COVID Two Years Into the Pandemic   

VIDEO: Long-term Cardiac Impacts of COVID-19 Two Years Into The Pandemic — Interview with Aaron Baggish, M.D.  

VIDEO: Long-COVID Presentations in Cardiology at Beaumont Hospital — Interview with Justin Trivax, M.D.  

VIDEO: Cardiac Presentations in COVID Long-haulers at Cedars-Sinai Hospital — Interview with Siddharth Singh, M.D.  

Find more COVID news and videos  

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging  

VIDEO: How to Image COVID-19 and Radiological Presentations of the Virus — Interview with Margarita Revzin, M.D.  

American Lung Association Addresses Awareness on World Lung Cancer Day 

Find more radiology related COVID news and videos  

John C. Breneman, M.D., medical director of the Cincinnati Children's/UC Health Proton Therapy Center, and the principal investigator of the FAST-01 trial, explains FLASH therapy and details on the trial. This study is testing the use of a single FLASH proton therapy session, rather than weeks of fractionated doses.

FLASH and hypo fractionated therapy have been among the hottest topics in radiation oncology. The premise of FLASH is to deliver extremely high doses of radiation to a tumor in one, short dose. Lab testing has shown this actually has a healthy tissue sparing capability and may help in reducing collateral damage.  

If this and other trials show benefit and improved outcomes from FLASH, it is possible this may become the primary treatment method for many cancers in the years to come. Reducing therapy to one treatment session also would open up much more time for proton centers so many more patients could be treated. It also would be a significant time and cost savings for patients and their families, who would not be required to stay at nearby hotels for extended stays during their course of treatment.  

Cincinnati Children's/UC Health Proton Therapy Center announced the completion of enrollment in FAST-01 (FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases) in October. This is the first human clinical trial of FLASH therapy, which centered on patients with metastases in arms and legs to avoid irradiating critical structures. If this trials shows benefits and low toxicity, followup studies will attempt more complex treatments in other parts of the body.

Related ASTRO 2021 Radiation Oncology Content:

7 Trends in Radiation Therapy at ASTRO 2021

Radiation Oncology Research Featured at ASTRO 2021 

Photo Gallery of Technologies at ASTRO 2021

VIDEO: Sedating Children With Movies Rather Than Drugs for Radiation Therapy — Interview with Jeffrey T. Chapman

VIDEO: 4 Radiation Oncology Technologies to Watch — Interview with Anthony Zietman, M.D.

VIDEO: Advances in Radiopharmaceutical Therapy — Interview with Ana Kiess, M.D., Ph.D.

VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare — Interview with Walter Curran, Jr. M.D., 

VIDEO: Elekta Harmony Radiotherapy System Walk-around

VIDEO Example of the Varian Noona Bidirection Oncology Patient Interface Software

VIDEO: Examples of Cherenkov Radiation Imaging During Radiation Therapy

Find more radiation oncology technology news

At RSNA 2021, Philips highlighted the launch of two new innovative CT systems – the multi-energy Spectral CT 7500 and the CT 5100 Incisive with embedded AI capabilities. ITN spoke with Wendy Winkle Lawless, CT Business Market Leader - North America, Philips, to learn more about these new systems.

With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their pharmaceutical diagnostics business. At RSNA 2021, Marco Campione, General Manager, Pharmaceutical Diagnostics Americas, GE Healthcare, shared how recent investments are helping to meet this increased demand.

Find more RSNA21 content here

At RSNA 2021, Fujifilm launched its new Velocity MRI system. It is designed to streamline workflow and enhance the patient experience with its open gantry, integrated RF coils and reconstruction techniques. Shawn Etheridge, Director, CT and MRI Marketing for Fujifilm, unveiled the system on the RSNA21 show floor.

Fujifilm Launches the Velocity MRI System at RSNA 2021

Additional RSNA21 content

Brian S. Bingham, M.D., chief resident in radiation oncology at the Vanderbilt University Medical Center, explains the practice-level and national cost burden of treatment-related prior authorization for academic radiation oncology practices. This was a highlighted study presented at the 2021 American Society of Radiation Oncology (ASTRO) annual meeting.

Photo Gallery of Technologies at ASTRO 2021

Radiation Oncology Research Featured at ASTRO 2021

Find more radiation oncology technology news

Bridget F. Koontz, M.D., chief medical officer at GenesisCare USA explains how to manage the complex needs of pelvic radiotherapy survivors. She offers an. overview of published evidence about the various toxicity types and approaches for managing them.

Photo Gallery of Technologies at ASTRO 2021

Radiation Oncology Research Featured at ASTRO 2021

Find more radiation oncology technology news

7 Trends in Radiation Therapy at ASTRO 2021

Sun Nuclear highlighted two resources for CT Quality Assurance at RSNA 2021. ITN visited their booth to learn more about the Mercury 4.0 Phantom and the Multi-Energy CT Phantom from Thomas Webb, Global Product Marketing Manager

Find more RSNA news and videos